Clinical Research on Stem Cell Therapy for Parkinson's Disease Trial Phase 1 Not yet recruiting Nov. 17, 2025
Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease Trial N/A Recruiting Nov. 17, 2025
Superior Colliculus Activity in Parkinson Disease: a Potential Marker? Trial N/A Completed Nov. 17, 2025
Efficacy of Cognitive Rehabilitation Using Virtual Reality and Computer-based Cognitive Stimulation on Cognitive Impairment Associated to Movement Disorders Trial N/A Completed Nov. 17, 2025
A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease Trial Phase 1 Completed Nov. 17, 2025
Influence of Autonomy on Motor Learning in People With Parkinson's Disease Trial N/A Recruiting Nov. 17, 2025
Mobility in Daily Life and Falls in Parkinson's Disease: Potential for Rehabilitation Trial N/A Active, not recruiting Nov. 16, 2025
[18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor Trial Phase 3 Completed Nov. 16, 2025
Effectiveness of Video-Based Upper Extremity Exercise Program in Parkinson's Disease Trial N/A Completed Nov. 16, 2025
Daily Amino Acid Supplementation for People With Parkinson's Disease Trial N/A Recruiting Nov. 12, 2025
Music Therapy to Prevent Hospital-acquired Delirium in Parkinson's Disease and Dementia With Lewy Bodies Trial N/A Completed Nov. 12, 2025
DB RCT for Specialized Phototherapy in Parkinson's Disease. Trial N/A Active, not recruiting Nov. 12, 2025
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments Trial Phase 1 Recruiting Nov. 11, 2025
Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control Trial N/A Recruiting Nov. 9, 2025
Targeted Motor Learning to Improve Gait for Individuals With Parkinson Disease Trial N/A Recruiting Nov. 5, 2025
Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease Trial N/A Active, not recruiting Nov. 4, 2025
Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease Trial Phase 1 Completed Nov. 3, 2025
Utilizing Neural Signatures and Virtual Reality to Advance DBS Programming Trial N/A Completed Nov. 3, 2025